safrole has been researched along with thapsigargin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Chang, HT; Chen, WC; Chou, CT; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Liu, SI; Tseng, LL | 1 |
| Chang, HT; Chen, IS; Chen, JS; Chen, WC; Cheng, HH; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Lin, HC; Liu, SI; Lu, YC | 1 |
| Chang, HT; Chen, IS; Chen, JS; Chen, WC; Cheng, HH; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Liu, SI; Lu, YC | 1 |
3 other study(ies) available for safrole and thapsigargin
| Article | Year |
|---|---|
Independent [Ca2+]i increases and cell proliferation induced by the carcinogen safrole in human oral cancer cells.
Topics: Calcium; Calcium Channel Blockers; Calcium Signaling; Calcium-Transporting ATPases; Carcinogens; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Humans; Nifedipine; Safrole; Thapsigargin; Time Factors | 2005 |
Safrole-induced cellular Ca2+ increases and death in human osteosarcoma cells.
Topics: Calcium; Calcium Channel Blockers; Calcium Signaling; Carcinogens; Cell Death; Cell Line, Tumor; Cell Survival; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Endoplasmic Reticulum; Fluorescent Dyes; Fura-2; Humans; Osteosarcoma; Phorbol Esters; Protein Kinase C; Safrole; Spectrometry, Fluorescence; Thapsigargin; Time Factors | 2006 |
The carcinogen safrole increases intracellular free Ca2+ levels and causes death in MDCK cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Carcinogens; Cell Line; Cell Survival; Culture Media; Cytosol; Dogs; Endoplasmic Reticulum; Estrenes; Extracellular Fluid; Intracellular Membranes; Kidney; Osmolar Concentration; Phosphodiesterase Inhibitors; Pyrrolidinones; Safrole; Thapsigargin; Type C Phospholipases | 2007 |